These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24591170)

  • 21. Deep brain stimulation in early stage Parkinson's disease.
    Charles D; Konrad PE; Davis TL; Neimat JS; Hacker ML; Finder SG
    Parkinsonism Relat Disord; 2015 Mar; 21(3):347-8. PubMed ID: 25547949
    [No Abstract]   [Full Text] [Related]  

  • 22. Subthalamic stimulation for Parkinson's disease: a new benchmark.
    Krack P
    J Neurol Neurosurg Psychiatry; 2011 Apr; 82(4):356-7. PubMed ID: 21335569
    [No Abstract]   [Full Text] [Related]  

  • 23. Delayed responses of subthalamic nucleus to deep brain stimulation in patients with Parkinson's disease.
    Shi L; Zhang K; Meng FG; Zhu GY; Chen YC; Zhou JJ; Zhou ZH; Zhang JG
    Parkinsonism Relat Disord; 2017 Jul; 40():76-77. PubMed ID: 28416330
    [No Abstract]   [Full Text] [Related]  

  • 24. There is no credible rational for deep brain stimulation in very early Parkinson's disease!
    Hariz M
    Parkinsonism Relat Disord; 2015 Mar; 21(3):345-6. PubMed ID: 25443552
    [No Abstract]   [Full Text] [Related]  

  • 25. Medication costs following subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Toft M; Dietrichs E
    Mov Disord; 2014 Feb; 29(2):275-6. PubMed ID: 23696136
    [No Abstract]   [Full Text] [Related]  

  • 26. Deep brain stimulation for Parkinson's disease: thinking about the long-term in the short-term.
    Obeso JA; Olanow W
    Mov Disord; 2011 Nov; 26(13):2303-4. PubMed ID: 22109849
    [No Abstract]   [Full Text] [Related]  

  • 27. Optimizing psychosocial adjustment after deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Shahmoon S; Jahanshahi M
    Mov Disord; 2017 Aug; 32(8):1155-1158. PubMed ID: 28504352
    [No Abstract]   [Full Text] [Related]  

  • 28. Subthalamic nucleus stimulation in Parkinson's disease: the other side of the medallion.
    Temel Y
    Exp Neurol; 2008 Jun; 211(2):321-3. PubMed ID: 18410927
    [No Abstract]   [Full Text] [Related]  

  • 29. Subthalamic deep brain stimulation versus best medical therapy for L-dopa responsive pain in Parkinson's disease.
    Sürücü O; Baumann-Vogel H; Uhl M; Imbach LL; Baumann CR
    Pain; 2013 Aug; 154(8):1477-9. PubMed ID: 23632230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson's disease: need for long-term clinical trials.
    Fasano A; Daniele A; Albanese A
    Mov Disord; 2011 Jun; 26(7):1370; author reply 1371. PubMed ID: 21469204
    [No Abstract]   [Full Text] [Related]  

  • 31. Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.
    Moreau C; Delval A; Defebvre L; Dujardin K; Duhamel A; Petyt G; Vuillaume I; Corvol JC; Brefel-Courbon C; Ory-Magne F; Guehl D; Eusebio A; Fraix V; Saulnier PJ; Lagha-Boukbiza O; Durif F; Faighel M; Giordana C; Drapier S; Maltête D; Tranchant C; Houeto JL; Debû B; Sablonniere B; Azulay JP; Tison F; Rascol O; Vidailhet M; Destée A; Bloem BR; Bordet R; Devos D;
    Lancet Neurol; 2012 Jul; 11(7):589-96. PubMed ID: 22658702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving outcomes of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Bari AA; Fasano A; Munhoz RP; Lozano AM
    Expert Rev Neurother; 2015 Oct; 15(10):1151-60. PubMed ID: 26377740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful long-term bilateral subthalamic nucleus deep brain stimulation in VPS35 Parkinson's disease.
    Fleury V; Wider C; Horvath J; Zacharia A; Bally J; Pollak P; Pollo C; Vingerhoets FJ; Burkhard PR
    Parkinsonism Relat Disord; 2013 Jul; 19(7):707-8. PubMed ID: 23623008
    [No Abstract]   [Full Text] [Related]  

  • 34. Hand bradykinesia improved by DBS in the dorsal putamen?
    Hariz M
    Mov Disord; 2012 Jan; 27(1):167-8; author reply 168-9. PubMed ID: 22134926
    [No Abstract]   [Full Text] [Related]  

  • 35. Modulation of dysarthropneumophonia by low-frequency STN DBS in advanced Parkinson's disease.
    Moreau C; Pennel-Ployart O; Pinto S; Plachez A; Annic A; Viallet F; Destée A; Defebvre L
    Mov Disord; 2011 Mar; 26(4):659-63. PubMed ID: 21506146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkinson's disease and pathological oscillatory activity: is the beta band the bad guy? - New lessons learned from low-frequency deep brain stimulation.
    Timmermann L; Florin E
    Exp Neurol; 2012 Jan; 233(1):123-5. PubMed ID: 22075181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of deep brain stimulation frequency on bradykinesia of Parkinson's disease.
    Huang H; Watts RL; Montgomery EB
    Mov Disord; 2014 Feb; 29(2):203-6. PubMed ID: 24395752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of subthalamic alpha activity to emotional stimuli correlates with depressive symptoms in Parkinson's disease.
    Huebl J; Schoenecker T; Siegert S; Brücke C; Schneider GH; Kupsch A; Yarrow K; Kühn AA
    Mov Disord; 2011 Feb; 26(3):477-83. PubMed ID: 21287598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Persistent" hyperkinetic movements after deep brain stimulation of the subthalamic nucleus for Parkinson's disease.
    Stathis PG; Smpiliris ME; Sakas DE
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1493-5. PubMed ID: 23266264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.